Interferon β1b, commonly used as therapeutic agent in multiple sclerosis (i.e., an inflammatory/autoimmune disease) induces the expression of an alternative-start transcript of the human NCOA7 gene, which may be involved in the protection from inflammatory oxidative stress (66). Here, NCOA7 is linked to multiple sclerosis.